RMOC Buprenorphine Long-acting Injection Guidance

This guidance is intended for use by substance misuse service providers (SMSP) in all settings, commissioners, community pharmacies and acute Trusts in England. It includes commencing treatment, practical considerations, transfer of care, clinical scenarios, and recommendations.

Specialist Pharmacy Service